Physician profile
Sanjay Mehta
NPI 1477572022
$17,791.66
in general payments reported to CMS, 2019-2025
20 companies · $7,785 in 2025
The $7,785 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,413 · 2020: $161 · 2021: $1,074 · 2022: $716 · 2023: $3,299 · 2024: $2,344 · 2025: $7,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,459 · Food and Beverage: $4,469 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,458.82 |
| Food and Beverage | $4,468.81 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,110.56 | 2019-2025 | Mitraclip, Optis, Pressurewire |
| Canon Medical Systems USA, INC. | $2,565.71 | 2025 | Interventional Angiography System |
| Philips North America LLC | $1,728.84 | 2019-2025 | Igt Devices Undivided, Eagle Eye, Ice 3d |
| Edwards Lifesciences Corporation | $1,531.98 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $1,144.03 | 2019 | |
| Medtronic, INC. | $641.39 | 2021-2025 | Symplicity G3, Concertotm, Abre |
| Shockwave Medical, INC | $374.85 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $162.98 | 2019 | |
| Biosense Webster, INC. | $124.68 | 2025 | Nuvision Ice Catheter |
| Janssen Pharmaceuticals, INC | $120.00 | 2024 | Xarelto |
| Boston Scientific Corporation | $109.81 | 2021-2025 | Watchman Access System |
| Abiomed | $64.02 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.49 | 2023-2024 | Lifevest |
| Cardiva Medical, INC. | $23.99 | 2025 | Cardiva Vascade 6/7f Vcs |
| Recor Medical INC | $23.61 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $15.59 | 2022 | |
| Siemens Medical Solutions USA, INC. | $14.13 | 2024 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.